These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 96668)

  • 1. Substrate specificity of hexosaminidase A isolated from the liver of a patient with a rare form (AB variant) of infantile GM2 gangliosidosis and control tissues.
    Sandhoff K; Conzelmann E; Nehrkorn H
    Adv Exp Med Biol; 1978; 101():727-30. PubMed ID: 96668
    [No Abstract]   [Full Text] [Related]  

  • 2. Purification, biochemical and immunological characterisation of hexosaminidase A from variant AB of infantile GM2 gangliosidosis.
    Conzelmann E; Sandhoff K; Nehrkorn H; Geiger B; Arnon R
    Eur J Biochem; 1978 Mar; 84(1):27-33. PubMed ID: 25769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.
    Conzelmann E; Sandhoff K
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3979-83. PubMed ID: 99746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
    Conzelmann E; Sandhoff K
    Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis.
    Erzberger A; Conzelmann E; Sandhoff K
    Clin Chim Acta; 1980 Dec; 108(3):361-8. PubMed ID: 6781795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
    Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
    Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.
    Kytzia HJ; Hinrichs U; Maire I; Suzuki K; Sandhoff K
    EMBO J; 1983; 2(7):1201-5. PubMed ID: 6226523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AB variant GM2 gangliosidosis: cerebrospinal fluid and neuropathologic characteristics.
    Kotagal S; Wenger DA; Alcala H; Gomez C; Horenstein S
    Neurology; 1986 Mar; 36(3):438-40. PubMed ID: 3081832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of the hexosaminidase A activator protein in a case of GM2 gangliosidosis; variant AB.
    Hechtman P; Gordon BA; Ng Ying Kin NM
    Pediatr Res; 1982 Mar; 16(3):217-22. PubMed ID: 6801612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of infantile and juvenile forms of GM2 gangliosidosis variant 0. Residual activities toward natural and different synthetic substrates.
    Kytzia HJ; Hinrichs U; Sandhoff K
    Hum Genet; 1984; 67(4):414-8. PubMed ID: 6436167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Function and relevance of activator proteins for glycolipid degradation].
    Sandhoff K
    Seikagaku; 1985 Feb; 57(2):87-102. PubMed ID: 3925052
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A.
    Hechtman P
    Can J Biochem; 1977 Apr; 55(4):315-24. PubMed ID: 858083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of the Cys138Arg substitution associated with the AB variant form of GM2 gangliosidosis: evidence that Cys138 is required for the recognition of the GM2 activator/GM2 ganglioside complex by beta-hexosaminidase A.
    Xie B; Rigat B; Smiljanic-Georgijev N; Deng H; Mahuran D
    Biochemistry; 1998 Jan; 37(3):814-21. PubMed ID: 9454570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate binding properties of the human liver hexosaminidase A activator protein.
    Hechtman P; Isaacs C; Smith-Jones L
    Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of an activator protein for the degradation of glycolipids GM2 and GA2 by hexosaminidase A.
    Conzelmann E; Sandhoff K
    Hoppe Seylers Z Physiol Chem; 1979 Dec; 360(12):1837-49. PubMed ID: 527942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein activators for the hydrolysis of GM1 and GM2 gangliosides.
    Li SC; Li YT
    Methods Enzymol; 1982; 83():588-95. PubMed ID: 6808306
    [No Abstract]   [Full Text] [Related]  

  • 17. Enzyme replacement in feline GM2 gangliosidosis: catabolic effects of human beta-hexosaminidase A.
    Rattazzi MC; Appel AM; Baker HJ
    Prog Clin Biol Res; 1982; 94():213-20. PubMed ID: 6214798
    [No Abstract]   [Full Text] [Related]  

  • 18. [N-Acetyl-beta-hexosaminidases. Present knowledge regarding chemical characterization and genetic relationships (author's transl)].
    Dhondt JL; Farriaux JP
    Pathol Biol (Paris); 1977 Sep; 25(7):493-504. PubMed ID: 413085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on beta-D-N-acetylhexosaminidase. Various isozymes in tissues of normal subjects and Sandhoff's disease patients.
    Srivastava SK; Wiktorowicz J; Klebe R; Awasthi YC
    Biochim Biophys Acta; 1975 Aug; 397(2):428-36. PubMed ID: 808239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of human hepatic H-acetyl-beta-D-hexosaminidose. A activity toward natural glycosphingolipid substrates.
    Bach G; Suzuki K
    J Biol Chem; 1975 Feb; 250(4):1328-32. PubMed ID: 1112809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.